SJ
Sven Jorg Willi Max Abend
About Sven Jorg Willi Max Abend
Data last updated:
Sven Jorg Willi Max Abend is a Director at Dfe Pharma India Private Limited (since 2025). The company operates in Business Services. Dfe Pharma India Private Limited reported revenue of ₹572 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dfe Pharma India Private Limited U24299TN2019FTC129309 | Director | 21 May 2025 | 2019 | ₹572 Cr (FY 2025) | Active |
Board colleagues of Sven Jorg Willi Max Abend
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Chitharanjan | 08582850 | Dfe Pharma India Private Limited | Director |
| Jaya Prabbu Subbaraj | 08595476 | Dfe Pharma India Private Limited | Director |
| Preetam Talanki Nagaraja Shetty | 09556889 | Dfe Pharma India Private Limited | Director |
| Shruthi Nandakumar | Dfe Pharma India Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sven Jorg Willi Max Abend
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sven Jorg Willi Max Abend
Sven Jorg Willi Max Abend currently holds 1 directorship: Dfe Pharma India Private Limited (Director, since 21 May 2025, revenue ₹572 Cr (FY 2025)).
Sven Jorg Willi Max Abend was first appointed on 21 May 2025 as Director at Dfe Pharma India Private Limited.
The current boards of Sven Jorg Willi Max Abend's companies include Aditya Chitharanjan (Dfe Pharma India Private Limited), Jaya Prabbu Subbaraj (Dfe Pharma India Private Limited), Preetam Talanki Nagaraja Shetty (Dfe Pharma India Private Limited), Shruthi Nandakumar (Dfe Pharma India Private Limited).